|7.03||+0.07 / +1.01%|
Data as of 3:59pm ET
|7.03||0.00 / 0.00%|
The 4 analysts offering 12-month price forecasts for Genocea Biosciences Inc have a median target of 24.50, with a high estimate of 40.00 and a low estimate of 22.00. The median estimate represents a +248.51% increase from the last price of 7.03.
The current consensus among 4 polled investment analysts is to Buy stock in Genocea Biosciences Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.